Clinical Trial Update: Efficacy and Dose Ranging Study of Seroguard [Phase 2]

View source ↗

Summary

Phase 2 study evaluating efficacy and dose-ranging of Seroguard for adhesion; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adhesion

Drugs mentioned

• Seroguard

Snippet

Sponsor: Pharmasyntez | Conditions: Adhesion | Phase 2 | Status: COMPLETED | Results posted: 2019-06-19